Page 4 of articles about vaccine in Press releases
Ceva’s acquisition of IDT swine vaccines delivers early promise with salmonella vaccine go-ahead in several European countries
Ceva will launch Salmoporc in Austria, Belgium, Czech Republic, Denmark, Hungary, Ireland, Italy, Netherlands, Portugal, Romania, Slovak Republic, United Kingdom through the remainder of 2019.
Ceva completes acquisition of IDT veterinary business assets
IDT’s strong range of swine vaccines will strengthen Ceva’s rapidly growing presence in this segment.
Zoetis receives EU Commission approval for variation group on Suvaxyn PRRS MLV Vaccine
Pirbright and ViroVet join forces to develop African swine fever antivirals
Commercial vaccines have been estimated to be several years away, so the development of alternative control methods is of critical global importance.
MSD launches PORCILIS® Ery+Parvo+Lepto, a triple-action vaccine with broad protection
Inovio and Plumbline Life Sciences establish animal health collaboration to develop a novel vaccine against ASF
The World’s first Plant-derived Porcine Marker Vaccine from Korea
HERBAVACTM CSF Green Marker is the World’s First plant-derived recombinant subunit vaccine against Classical Swine Fever Virus and can Differentiate Infected from Vaccinated Animals.
Boehringer Ingelheim launches first veterinary vaccines produced in China
The first local manufacturing plant, wholly-owned by a multinational animal health company, focuses on the China swine market.
Pharmgate and ECO Animal Health expand partnership
New vaccine protects pigs against pandemic flu strain
A newly-developed vaccine against swine influenza is being launched in the UK by Hysolv Animal Health UK.
MSD Animal Health launches IDAL® 3G Twin, the first needle-free and intradermal device with two injector heads for swine vaccination
New device in combination with PORCILIS® vaccines provides quick and easy prevention of two of the most common swine diseases.
Elanco Animal Health introduces new respiratory PRRS vaccine
IDT Biologika acquires Dr. Felgenträger
The pharmaceuticals company intends to use this takeover to continue expanding its herd-specific vaccine business.
Five million doses of Prevtec Microbia’s bivalent vaccine Coliprotec® F4/F18 Sold in the European Union
Competition to zap bugs on screen – and on the farm
A survey showed that one-third of herds tested positive to the causative agent of bowel oedema, the strains of E coli which excrete lethal shiga toxins.